Mark D. Tyson

3.1k total citations · 1 hit paper
125 papers, 2.1k citations indexed

About

Mark D. Tyson is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Urology. According to data from OpenAlex, Mark D. Tyson has authored 125 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Surgery, 45 papers in Pulmonary and Respiratory Medicine and 34 papers in Urology. Recurrent topics in Mark D. Tyson's work include Bladder and Urothelial Cancer Treatments (59 papers), Urinary and Genital Oncology Studies (31 papers) and Urological Disorders and Treatments (23 papers). Mark D. Tyson is often cited by papers focused on Bladder and Urothelial Cancer Treatments (59 papers), Urinary and Genital Oncology Studies (31 papers) and Urological Disorders and Treatments (23 papers). Mark D. Tyson collaborates with scholars based in United States, Spain and Canada. Mark D. Tyson's co-authors include Sam S. Chang, Lori B. Lerner, Mitchell R. Humphreys, Erik P. Castle, Daniel A. Barocas, Paul E. Andrews, Matthew J. Resnick, David F. Penson, Ramin Yadegari and Dongfang Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Clinical Oncology.

In The Last Decade

Mark D. Tyson

114 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years

2017 245 citations Daniel A. Barocas, JoAnn Alvarez et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark D. Tyson United States	24	906	805	465	265	264	125	2.1k
Nicolas Kalfa France	29	323 0.4×	986 1.2×	556 1.2×	238 0.9×	80 0.3×	135	2.4k
Sami Arap Brazil	29	692 0.8×	1.1k 1.4×	792 1.7×	509 1.9×	105 0.4×	130	2.4k
Jonathan C. Routh United States	33	1.1k 1.2×	1.1k 1.4×	1.6k 3.5×	415 1.6×	183 0.7×	196	3.7k
Adrian Charles Australia	33	719 0.8×	654 0.8×	139 0.3×	187 0.7×	180 0.7×	129	3.2k
Sarah K. Holt United States	30	661 0.7×	1.2k 1.5×	316 0.7×	207 0.8×	340 1.3×	160	3.0k
Françoise Müller France	39	595 0.7×	1.0k 1.3×	595 1.3×	338 1.3×	61 0.2×	192	4.2k
William Carlos Nahas Brazil	24	831 0.9×	638 0.8×	255 0.5×	200 0.8×	178 0.7×	178	1.9k
James F. Borin United States	19	641 0.7×	474 0.6×	120 0.3×	77 0.3×	100 0.4×	48	1.3k
Uğur Yılmaz Türkiye	23	326 0.4×	717 0.9×	82 0.2×	93 0.4×	340 1.3×	112	1.9k
Marian K. Bakker Netherlands	27	217 0.2×	412 0.5×	99 0.2×	171 0.6×	68 0.3×	73	2.2k

Countries citing papers authored by Mark D. Tyson

Since Specialization

Citations

This map shows the geographic impact of Mark D. Tyson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Tyson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Tyson more than expected).

Fields of papers citing papers by Mark D. Tyson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. Tyson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Tyson. The network helps show where Mark D. Tyson may publish in the future.

Co-authorship network of co-authors of Mark D. Tyson

This figure shows the co-authorship network connecting the top 25 collaborators of Mark D. Tyson. A scholar is included among the top collaborators of Mark D. Tyson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark D. Tyson. Mark D. Tyson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tyson, Mark D., et al.. (2025). BOND-003- COHORT P: A MULTI-NATIONAL, SINGLE-ARM STUDY OF INTRAVESICAL CRETOSTIMOGENE GRENADENOREPVEC FOR THE TREATMENT OF HIGH-RISK, PAPILLARY ONLY, BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER. Urologic Oncology Seminars and Original Investigations. 43(3). 50–51. 2 indexed citations

Nguyen, Mimi Thi, et al.. (2025). Real-world outcomes of nadofaragene firadenovec in BCG-unresponsive non-muscle invasive bladder cancer.. Journal of Clinical Oncology. 43(5_suppl). 716–716. 2 indexed citations

Tyson, Mark D., et al.. (2024). Testicular cancer malpractice trends. Urologic Oncology Seminars and Original Investigations. 43(1). 65.e17–65.e21.

Ahmed, Mohamed E., Jack R. Andrews, Ahmed Mahmoud, et al.. (2024). PD34-03 INTRAOPERATIVE TRANEXAMIC ACID IN RADICAL CYSTECTOMY: IMPACT ON BLEEDING, THROMBOEMBOLISM, AND CANCER-SPECIFIC SURVIVAL. The Journal of Urology. 211(5S). 1 indexed citations

Ahmed, Mohamed E., Jack R. Andrews, Ahmed Mahmoud, et al.. (2024). Intraoperative Tranexamic Acid in Radical Cystectomy: Impact on Bleeding, Thromboembolism, and Survival Outcomes. The Journal of Urology. 213(4). 447–454. 1 indexed citations

Mi, Lanyu, et al.. (2024). Intraoperative magnesium sulfate is not associated with improved pain control after urologic procedures. SHILAP Revista de lepidopterología. 13(1). 91–91. 1 indexed citations

Ristau, Benjamin T., Matthew Mossanen, Mark D. Tyson, et al.. (2023). Patient reported treatment burden and attitudes towards in-home intravesical therapy among patients with bladder cancer. Urologic Oncology Seminars and Original Investigations. 42(2). 29.e17–29.e22. 4 indexed citations

Nevo, Amihay, Karen Stern, Jonathan P. Moore, et al.. (2020). The impact of phone counseling on urinary stone prevention. World Journal of Urology. 39(5). 1625–1629. 5 indexed citations

Ziegelmann, Matthew, Jason Joseph, Amy E. Glasgow, et al.. (2019). Wide Variation in Opioid Prescribing After Urological Surgery in Tertiary Care Centers. Mayo Clinic Proceedings. 94(2). 262–274. 32 indexed citations

10.

Packiam, Vignesh T., Mark D. Tyson, Matvey Tsivian, et al.. (2019). The association of anxiety and depression with perioperative and oncologic outcomes among patients with clear cell renal cell carcinoma undergoing nephrectomy. Urologic Oncology Seminars and Original Investigations. 38(2). 41.e19–41.e27. 8 indexed citations

11.

Rose, Kyle, Anojan Navaratnam, Haidar Abdul-Muhsin, et al.. (2019). Comparison of Open and Robot Assisted Radical Nephrectomy With Level I and II Inferior Vena Cava Tumor Thrombus: The Mayo Clinic Experience. Urology. 136. 152–157. 23 indexed citations

12.

Tyson, Mark D., Tatsuki Koyama, Dan Lee, et al.. (2018). Effect of Prostate Cancer Severity on Functional Outcomes After Localized Treatment: Comparative Effectiveness Analysis of Surgery and Radiation Study Results. European Urology. 74(1). 26–33. 20 indexed citations

13.

O’Neil, Brock, Mark D. Tyson, Amy J. Graves, et al.. (2017). The influence of provider characteristics and market forces on response to financial incentives.. PubMed. 23(11). 662–667. 2 indexed citations

14.

Lee, Daniel J., Mark D. Tyson, & Sam S. Chang. (2017). Conduit Urinary Diversion. Urologic Clinics of North America. 45(1). 25–36. 12 indexed citations

15.

Tyson, Mark D. & Daniel A. Barocas. (2017). Improving quality through clinical registries in urology. Current Opinion in Urology. 27(4). 375–379. 14 indexed citations

16.

Abdul-Muhsin, Haidar, Mark D. Tyson, Karen Stern, Rafael Núñez-Nateras, & Mitchell R. Humphreys. (2016). The impact of training on the perioperative and intermediate functional outcomes after holmium laser enucleation of the prostate.. PubMed. 23(6). 8557–8563. 3 indexed citations

17.

Tyson, Mark D. & Sam S. Chang. (2016). Enhanced Recovery Pathways Versus Standard Care After Cystectomy: A Meta-analysis of the Effect on Perioperative Outcomes. European Urology. 70(6). 995–1003. 159 indexed citations

18.

Tyson, Mark D., JoAnn Alvarez, Tatsuki Koyama, et al.. (2016). Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR Study. European Urology. 72(2). 307–314. 19 indexed citations

19.

Abdul-Muhsin, Haidar, Mark D. Tyson, Paul E. Andrews, et al.. (2015). Analysis of Benign Prostatic Hyperplasia Patients' Perspective Through a Third Party-administered Survey. Urology. 88. 155–160. 12 indexed citations

20.

Tyson, Mark D., et al.. (2014). The Impact of Ischemia on Long-Term Renal Function After Partial Nephrectomy in the Two Kidney Model. Journal of Endourology. 29(4). 474–478. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact